Literature DB >> 33431910

Impacts of monocular, binocular, and functional visual acuity on vision-related quality of life in patients with type 2 diabetes.

Kuo-Meng Liao1, Wei-Chi Wu2, Yuh Jang3, Fan-Ya Su4, Li-Ting Tsai5.   

Abstract

Although the association between visual acuity (VA) and vision-related quality of life (VRQoL) has been well reported in patients with type 2 diabetes mellitus (T2DM), little is known about how unilateral and bilateral VA affects daily performance in such patients. For this cross-sectional study, patients were recruited from the Diabetes Shared Care Network of the Division of Endocrinology and Metabolism, Zhong-Xiao Branch, Taipei City Hospital in Taiwan. Ninety patients with T2DM (51 men and 39 women) with a mean age of 60.3 ± 10.5 (standard deviation) years, 47% of whom had diabetic retinopathy, were included. The purposes were to compare the impacts of VA in the better eye, both eyes, and three forms of functional acuity scores (FAS) on VRQoL in patients with T2DM. VRQoL and corrected VA were assessed with the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) and Early Treatment Diabetic Retinopathy Study (ETDRS) chart, respectively. Three FAS algorithms proposed by Colenbrander and the American Medical Association were used to assess FAS. Regression analyses were performed to determine the correlations among the five types of VA, the original composite scores, and the Rasch-calibrated composite scores of the NEI VFQ-25 on all patients with T2DM and on the same patients stratified by diabetic retinopathy (DR) and no-DR. The VA of both eyes had a higher impact on VRQoL and revealed a lower reduction estimated by the two forms of composite scores than did the VA of the better eye and three FAS algorithms (compared with binocular VA β estimates, - 14.5%, - 15.8%, - 29.3%, and - 11.8% for original composite scores, and - 16.1%, - 14.0%, - 24.6%, and 10.3% for Rasch-calibrated composite scores). When the T2DM group was stratified into DR and no-DR groups, significant associations between VA and VRQoL were observed only in the DR group. The VA of both eyes also had the greatest impact and reduction after stratification. The results indicated that unilateral better-eye VA and VA estimated by the three FAS algorithms seems to underestimate the impact of visual impairment on self-report VRQoL in patients with T2DM. This study provides empirical support for the importance of binocular VA assessment in regular clinical diabetes eye care.

Entities:  

Mesh:

Year:  2021        PMID: 33431910      PMCID: PMC7801718          DOI: 10.1038/s41598-020-79483-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  35 in total

1.  Development of the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  C M Mangione; P P Lee; P R Gutierrez; K Spritzer; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  2001-07

2.  Visual functioning and health-related quality of life in diabetic patients about to undergo anti-vascular endothelial growth factor treatment for sight-threatening macular edema.

Authors:  Therese Granström; Henrietta Forsman; Janeth Leksell; Siba Jani; Aseel Modher Raghib; Elisabet Granstam
Journal:  J Diabetes Complications       Date:  2015-08-01       Impact factor: 2.852

3.  Association of Glaucoma-Related, Optical Coherence Tomography-Measured Macular Damage With Vision-Related Quality of Life.

Authors:  Alisa J Prager; Donald C Hood; Jeffrey M Liebmann; C Gustavo De Moraes; Lama A Al-Aswad; Qi Yu; George A Cioffi; Dana M Blumberg
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

4.  The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Authors:  R Klein; S E Moss; B E Klein; P Gutierrez; C M Mangione
Journal:  Arch Ophthalmol       Date:  2001-05

5.  Psychometric validation of the Taiwan Chinese version of the 25-Item National Eye Institute Visual Functioning Questionnaire.

Authors:  Jen-Chieh Lin; Wei-Chu Chie
Journal:  J Eval Clin Pract       Date:  2009-08-27       Impact factor: 2.431

6.  Using Uniocular Visual Acuity Substantially Underestimates the Impact of Visual Impairment on Quality of Life Compared with Binocular Visual Acuity.

Authors:  Ryan Eyn Kidd Man; Alfred Tau Liang Gan; Eva K Fenwick; Sahil Thakur; Preeti Gupta; Zhen Ling Teo; Ching-Yu Cheng; Tien Yin Wong; Ecosse L Lamoureux
Journal:  Ophthalmology       Date:  2020-02-08       Impact factor: 12.079

7.  Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.

Authors:  Rose A Gubitosi-Klug; Wanjie Sun; Patricia A Cleary; Barbara H Braffett; Lloyd Paul Aiello; Arup Das; William Tamborlane; Ronald Klein
Journal:  JAMA Ophthalmol       Date:  2016-02       Impact factor: 7.389

8.  A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications.

Authors:  Nuria Alcubierre; Esther Rubinat; Alicia Traveset; Montserrat Martinez-Alonso; Marta Hernandez; Carmen Jurjo; Didac Mauricio
Journal:  Health Qual Life Outcomes       Date:  2014-08-20       Impact factor: 3.186

9.  The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy.

Authors:  Louis S Matza; Matthew D Rousculp; Karen Malley; Kristina S Boye; Alan Oglesby
Journal:  Health Qual Life Outcomes       Date:  2008-11-07       Impact factor: 3.186

10.  Detecting Visual Function Abnormality with a Contrast-Dependent Visual Test in Patients with Type 2 Diabetes.

Authors:  Li-Ting Tsai; Kuo-Meng Liao; Yuh Jang; Fu-Chang Hu; Wei-Chi Wu
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

View more
  1 in total

1.  Anxiety levels moderate the association between visual acuity and health-related quality of life in chronic eye disease patients.

Authors:  Hugo Senra; Laura Hernandez-Moreno; Natacha Moreno; António Filipe Macedo
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.